Clinical Trial Update: Albumin-bound Paclitaxel Combined With Liposomal Doxorubicin in the Treatment of Advanced or Unresectable Angiosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating albumin-bound paclitaxel with liposomal doxorubicin for advanced or unresectable angiosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiosarcoma

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Angiosarcoma Metastatic | Phase 2 | Status: UNKNOWN